Northern Trust’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Northern Trust’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,716	Closed	-$2K	–	4255
2016 Q3	$2K	Hold	12,716	–	–	﹤0.01%	4180
2016 Q2	$4K	Hold	12,716	–	–	﹤0.01%	4198
2016 Q1	$2K	Hold	12,716	–	–	﹤0.01%	4240
2015 Q4	$22K	Hold	12,716	–	–	﹤0.01%	4165
2015 Q3	$24K	Buy	+12,716	New	+$30.3K	﹤0.01%	4171
2015 Q2	–	Sell	-10,554	Closed	-$46K	–	4314
2015 Q1	$46K	Hold	10,554	–	–	﹤0.01%	4164
2014 Q4	$51K	Hold	10,554	–	–	﹤0.01%	4095
2014 Q3	$44K	Sell	10,554 -4,845	-31%	-$22.6K	﹤0.01%	4158
2014 Q2	$90K	Buy	15,399 +349	+2%	+$1.98K	﹤0.01%	4031
2014 Q1	$96K	Buy	+15,050	New	+$136K	﹤0.01%	3951

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Northern Trust's TLOG Position: Q4 2016 in Review

Northern Trust sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 12,716 shares — an estimated $2K sold.

Northern Trust first reported a position in TLOG in Q1 2014 and held it in 10 quarters. The position peaked at $96K in Q1 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Northern Trust reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Northern Trust sold 12,716 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $2K.
Northern Trust first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2014 and held it in 10 quarters.
Northern Trust's TetraLogic Pharmaceuticals Corporation position peaked at $96K in Q1 2014.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.